Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 3Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1CNS 1

Conditions

Sexual Infantilism 1Polycystic Ovary Syndrome 1Overweight 1Obesity 1Insulin Resistance 1Craniopharyngioma 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Exenatide × Clear all
NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed
10 enrolled 15 charts
CNSOther

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

NCT00344851 2007-07-11

Exenatide and Metformin Therapy in Overweight Women With PCOS

Metabolic Center of Louisiana Research Foundation

Phase 2 Completed
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡